SCHEMBL10749667

SCHEMBL10749667

O=c1c2ccc(Cl)c(Cl)c2[se]n1-c1ncccn1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 2/20 0.33
▸ METAP2 P50579 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ METAP1 P53582 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ EP300 Q09472 1/20 0.31
▸ CREBBP Q92793 1/20 0.31
▸ KAT2A Q92830 1/20 0.31
▸ MAT2A P31153 1/20 0.30
▸ APP P05067 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501985 0.87 GAA (0.38) KAT2BKDM4EALDH1A1EP300MAT2A
SCHEMBL10747318 0.82 KDM4E (0.32) METAP2KDM4EBRD4LMNAHSP90AA1
SCHEMBL10502358 0.78 METAP2 (0.51) METAP2KDM4ELMNAMAPTALDH1A1
SCHEMBL10745150 0.73 METAP2 (0.45) METAP2MAT2A
SCHEMBL10748041 0.72 METAP2 (0.38) KAT2BMETAP2KDM4ELMNAMAPT
SCHEMBL10748298 0.71 METAP2 (0.46) KAT2BMETAP2KDM4EALDH1A1
SCHEMBL5916517 0.71 GAA (0.42) KDM4EMAPTALDH1A1
SCHEMBL10746363 0.71 NQO2 (0.36) KDM4ELMNAMAPTALDH1A1
SCHEMBL10745932 0.70 METAP2 (0.45) METAP2KDM4ELMNAMAPTALDH1A1
SCHEMBL10501949 0.70 GAA (0.34) KDM4EALDH1A1MAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback